{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:17:58Z","timestamp":1791404278113,"version":"4.3.3"},"reference-count":62,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.11634","type":"journal-article","created":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:24:38Z","timestamp":1652268278000},"page":"e2211634","source":"Crossref","is-referenced-by-count":28,"title":["Analysis of Stimulant Prescriptions and Drug-Related Poisoning Risk Among Persons Receiving Buprenorphine Treatment for Opioid Use Disorder"],"prefix":"10.1001","volume":"5","author":[{"given":"Carrie M.","family":"Mintz","sequence":"first","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin Y.","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ned J.","family":"Presnall","sequence":"additional","affiliation":[{"name":"Department of Social Work, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah M.","family":"Hartz","sequence":"additional","affiliation":[{"name":"Department of Social Work, Washington University in St Louis, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances R.","family":"Levin","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, College of Physicians and Surgeons of Columbia University, New York, New York"},{"name":"Division of Substance Use Disorders, New York State Psychiatric Institute, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey F.","family":"Scherrer","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, St Louis University, St. Louis, Missouri"},{"name":"Department of Health and Outcomes Research, St. Louis University, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Bierut","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Grucza","sequence":"additional","affiliation":[{"name":"Department of Family and Community Medicine, St Louis University, St. Louis, Missouri"},{"name":"Department of Health and Outcomes Research, St. Louis University, St Louis, Missouri"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,5,11]]},"reference":[{"issue":"394","key":"zoi220347r1","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2019.","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief"},{"issue":"8","key":"zoi220347r3","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1001\/jamapsychiatry.2018.1471","article-title":"Causes of death after nonfatal opioid overdose.","volume":"75","author":"Olfson","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"zoi220347r4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","article-title":"Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study.","volume":"169","author":"Larochelle","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"zoi220347r5","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2105\/AJPH.2017.304132","article-title":"Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014.","volume":"108","author":"Zibbell","year":"2018","journal-title":"Am J Public Health"},{"issue":"11","key":"zoi220347r6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0242165","article-title":"Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018.","volume":"15","author":"Capizzi","year":"2020","journal-title":"PLoS One"},{"issue":"8","key":"zoi220347r7","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/00005053-199908000-00005","article-title":"Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment.","volume":"187","author":"King","year":"1999","journal-title":"J Nerv Ment Dis"},{"issue":"1","key":"zoi220347r8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000321259","article-title":"Influence of attention deficit hyperactivity disorder and conduct disorder on opioid dependence severity and psychiatric comorbidity in chronic methadone-maintained patients.","volume":"17","author":"Carpentier","year":"2011","journal-title":"Eur Addict Res"},{"key":"zoi220347r9","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.psychres.2017.01.052","article-title":"Co-occurring attention deficit hyperactivity disorder symptoms in adults affected by heroin dependence: patients characteristics and treatment needs.","volume":"250","author":"Lugoboni","year":"2017","journal-title":"Psychiatry Res"},{"issue":"3","key":"zoi220347r10","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0740-5472(01)00193-3","article-title":"Dual diagnosis and successful participation of adolescents in substance abuse treatment.","volume":"21","author":"Wise","year":"2001","journal-title":"J Subst Abuse Treat"},{"issue":"9","key":"zoi220347r11","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.addbeh.2004.03.041","article-title":"Impact of attention-deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community.","volume":"29","author":"Levin","year":"2004","journal-title":"Addict Behav"},{"key":"zoi220347r13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drugalcdep.2014.09.782","article-title":"National record linkage study of mortality for a large cohort of opioid users ascertained by drug treatment or criminal justice sources in England, 2005-2009.","volume":"146","author":"Pierce","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"zoi220347r14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users.","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi220347r15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.v115.2","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17.","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction"},{"issue":"4","key":"zoi220347r16","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis.","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr Opin Psychiatry"},{"issue":"2","key":"zoi220347r17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/ajad.v30.2","article-title":"Increasing heroin-methamphetamine (goofball) use and related morbidity among Seattle area people who inject drugs.","volume":"30","author":"Glick","year":"2021","journal-title":"Am J Addict"},{"issue":"6","key":"zoi220347r18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","article-title":"Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013-2019.","volume":"70","author":"Mattson","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"pt 2","key":"zoi220347r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106541","article-title":"The fourth wave of the US opioid epidemic and its implications for the rural US: a federal perspective.","volume":"152","author":"Jenkins","year":"2021","journal-title":"Prev Med"},{"key":"zoi220347r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108764","article-title":"Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort.","volume":"225","author":"Morgan","year":"2021","journal-title":"Drug Alcohol Depend"},{"key":"zoi220347r22","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.108130","article-title":"Age disparities in six-month treatment retention for opioid use disorder.","volume":"213","author":"Mintz","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"9358","key":"zoi220347r23","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-Year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial.","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet"},{"issue":"1","key":"zoi220347r24","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0376-8716(95)01186-2","article-title":"A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.","volume":"40","author":"Johnson","year":"1995","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi220347r25","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder.","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Netw Open"},{"key":"zoi220347r26","doi-asserted-by":"publisher","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"zoi220347r27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugalcdep.2019.02.031","article-title":"Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort.","volume":"200","author":"Morgan","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"9","key":"zoi220347r28","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1111\/add.v115.9","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services.","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"issue":"12","key":"zoi220347r29","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1001\/jamapsychiatry.2015.2146","article-title":"Effects of group psychotherapy, individual counseling, methylphenidate, and placebo in the treatment of adult attention-deficit\/hyperactivity disorder: a randomized clinical trial.","volume":"72","author":"Philipsen","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"7","key":"zoi220347r30","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder.","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"2","key":"zoi220347r31","first-page":"86","article-title":"Stimulant medication prescribing practices within a VA Health Care System.","volume":"37","author":"Richmond","year":"2020","journal-title":"Fed Pract"},{"issue":"6","key":"zoi220347r32","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/1087054715605915","article-title":"Recent trends in stimulant usage.","volume":"20","author":"Safer","year":"2016","journal-title":"J Atten Disord"},{"issue":"5","key":"zoi220347r33","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1111\/add.v113.5","article-title":"Risk of amphetamine use disorder and mortality among incident users of prescribed stimulant medications in the Veterans Administration.","volume":"113","author":"Westover","year":"2018","journal-title":"Addiction"},{"issue":"1","key":"zoi220347r34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4088\/JCP.12m07975","article-title":"Trends in office-based treatment of adults with stimulants in the United States.","volume":"74","author":"Olfson","year":"2013","journal-title":"J Clin Psychiatry"},{"issue":"8","key":"zoi220347r35","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1176\/appi.ajp.2018.17091048","article-title":"Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States.","volume":"175","author":"Compton","year":"2018","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi220347r36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s10567-014-0177-z","article-title":"Misuse of stimulant medication among college students: a comprehensive review and meta-analysis.","volume":"18","author":"Benson","year":"2015","journal-title":"Clin Child Fam Psychol Rev"},{"key":"zoi220347r37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.drugalcdep.2015.10.006","article-title":"Differentiating patterns of prescription stimulant medical and nonmedical use among youth 10-18 years of age.","volume":"157","author":"Wang","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"zoi220347r38","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/10550490601082783","article-title":"Treatment strategies for co-occurring ADHD and substance use disorders.","volume":"16","author":"Mariani","year":"2007","journal-title":"Am J Addict"},{"issue":"1","key":"zoi220347r39","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1177\/0269881114544777","article-title":"Pharmacological treatment of attention deficit hyperactivity disorder with co-morbid drug dependence.","volume":"29","author":"Cunill","year":"2015","journal-title":"J Psychopharmacol"},{"issue":"9","key":"zoi220347r40","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1176\/appi.ajp.2017.16060686","article-title":"ADHD medication and substance-related problems.","volume":"174","author":"Quinn","year":"2017","journal-title":"Am J Psychiatry"},{"issue":"1","key":"zoi220347r41","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.drugalcdep.2006.07.004","article-title":"Treatment of cocaine dependent treatment seekers with adult ADHD: double-blind comparison of methylphenidate and placebo.","volume":"87","author":"Levin","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"6","key":"zoi220347r42","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/jamapsychiatry.2015.41","article-title":"Extended-release mixed amphetamine salts vs placebo for comorbid adult attention-deficit\/hyperactivity disorder and cocaine use disorder: a randomized clinical trial.","volume":"72","author":"Levin","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1-2","key":"zoi220347r43","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.drugalcdep.2009.11.006","article-title":"Sustained release methylphenidate for the treatment of ADHD in amphetamine abusers: a pilot study.","volume":"108","author":"Konstenius","year":"2010","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"zoi220347r44","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.drugalcdep.2005.06.012","article-title":"Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.","volume":"81","author":"Levin","year":"2006","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"zoi220347r45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1080\/15504263.2013.867657","article-title":"Stimulant medication for ADHD in opioid maintenance treatment.","volume":"10","author":"Abel","year":"2014","journal-title":"J Dual Diagn"},{"key":"zoi220347r46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jsat.2015.05.001","article-title":"Risk factors for relapse and higher costs among Medicaid members with opioid dependence or abuse: opioid agonists, comorbidities, and treatment history.","volume":"57","author":"Clark","year":"2015","journal-title":"J Subst Abuse Treat"},{"issue":"11","key":"zoi220347r47","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder.","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"2","key":"zoi220347r48","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.20m13598","article-title":"Pharmacotherapy for attention-deficit\/hyperactivity disorder and retention in outpatient substance use disorder treatment: a retrospective cohort study.","volume":"82","author":"Kast","year":"2021","journal-title":"J Clin Psychiatry"},{"key":"zoi220347r49","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.108886","article-title":"An examination between treatment type and treatment retention in persons with opioid and co-occurring alcohol use disorders.","volume":"226","author":"Mintz","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"zoi220347r50","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1176\/appi.ajp.2020.20081174","article-title":"Association between benzodiazepine or z-drug prescriptions and drug-related poisonings among patients receiving buprenorphine maintenance: a case-crossover analysis.","volume":"178","author":"Xu","year":"2021","journal-title":"Am J Psychiatry"},{"issue":"2","key":"zoi220347r51","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.0061","article-title":"Association of opioid use disorder treatment with alcohol-related acute events.","volume":"4","author":"Xu","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi220347r52","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1093\/ije\/dyu081","article-title":"Exchangeability in the case-crossover design.","volume":"43","author":"Mittleman","year":"2014","journal-title":"Int J Epidemiol"},{"issue":"1","key":"zoi220347r54","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1467-9531.2006.00177.x","article-title":"Fixed-effects methods for the analysis of nonrepeated events.","volume":"36","author":"Allison","year":"2006","journal-title":"Sociol Methodol"},{"issue":"10","key":"zoi220347r55","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/aje\/kww079","article-title":"Persistent user bias in case-crossover studies in pharmacoepidemiology.","volume":"184","author":"Hallas","year":"2016","journal-title":"Am J Epidemiol"},{"issue":"7557","key":"zoi220347r56","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/bmj.333.7557.18","article-title":"The healthy adherer and the placebo effect.","volume":"333","author":"Chewning","year":"2006","journal-title":"BMJ"},{"issue":"3","key":"zoi220347r57","doi-asserted-by":"publisher","first-page":"315","DOI":"10.3200\/JACH.57.3.315-324","article-title":"Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.","volume":"57","author":"DeSantis","year":"2008","journal-title":"J Am Coll Health"},{"issue":"3","key":"zoi220347r58","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13548500220139386","article-title":"Illicit use of psychostimulants among college students: a preliminary study.","volume":"7","author":"Low","year":"2002","journal-title":"Psychol Health Med"},{"issue":"3","key":"zoi220347r59","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1001\/jamapsychiatry.2013.4174","article-title":"Serious transport accidents in adults with attention-deficit\/hyperactivity disorder and the effect of medication: a population-based study.","volume":"71","author":"Chang","year":"2014","journal-title":"JAMA Psychiatry"},{"key":"zoi220347r60","doi-asserted-by":"publisher","first-page":"g3769","DOI":"10.1136\/bmj.g3769","article-title":"Drug treatment for attention-deficit\/hyperactivity disorder and suicidal behaviour: register based study.","volume":"348","author":"Chen","year":"2014","journal-title":"BMJ"},{"issue":"3","key":"zoi220347r61","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11920-017-0769-7","article-title":"Towards precision addiction treatment: new findings in co-morbid substance use and attention-deficit hyperactivity disorders.","volume":"19","author":"Luo","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"8","key":"zoi220347r62","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1046\/j.1360-0443.2003.00474.x","article-title":"The ratio of non-fatal to fatal heroin overdose.","volume":"98","author":"Darke","year":"2003","journal-title":"Addiction"},{"key":"zoi220347r20","doi-asserted-by":"crossref","DOI":"10.17226\/25310","volume-title":"Medications for Opioid Use Disorder Save Lives","author":"Leshner","year":"2019"},{"key":"zoi220347r2","unstructured":"National Institute on Drug Abuse. Overdose death rates. January 20, 2022. Accessed February 8, 2022. https:\/\/nida.nih.gov\/drug-topics\/trends-statistics\/overdose-death-rates"},{"key":"zoi220347r12","unstructured":"Substance Abuse and Mental Health Services Administration. SAMSHA\u2019s public online data analysis system. National Survey on Drug Use and Health. 2022. Accessed February 8, 2022. https:\/\/pdas.samhsa.gov:443\/"},{"key":"zoi220347r53","unstructured":"Allison? P. Fixed effects regression methods in SAS. Paper 184-31. 2006. Accessed April 8, 2022. https:\/\/citeseerx.ist.psu.edu\/viewdoc\/download?doi=10.1.1.176.1548&rep=rep1&type=pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2792174\/mintz_2022_oi_220347_1651687170.8993.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,11]],"date-time":"2022-05-11T11:24:44Z","timestamp":1652268284000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2792174"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,11]]},"references-count":62,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.11634","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,11]]}}}